An SNP-dependent cancer-testis antigenic epitope serves as a promising immunotherapeutic target for cancer

Area of Science:

• Immunology
• Oncology
• Genetics

Background:

• T cells are crucial for immune surveillance, recognizing peptides presented by human leukocyte antigen (HLA) molecules.
• Cancer-testis (CT) antigens are highly specific targets for cancer immunotherapy due to their restricted expression.
• Acral melanoma, a type of skin cancer, often exhibits high tumor-infiltrating lymphocyte (TIL) infiltration.

Purpose of the Study:

• To identify novel cancer-testis antigenic epitopes in acral melanoma.
• To investigate the role of single nucleotide polymorphisms (SNPs) in conferring immunogenicity to CT antigens.
• To evaluate the utility of forward immunology approaches in cancer antigen discovery.

Main Methods:

• Antigen screening of T cell receptors from tumor-infiltrating lymphocytes (TILs) in acral melanoma.
• Utilizing cDNA expression cloning, a forward immunology technique.
• Analyzing T cell responses to identify recognized epitopes and associated genetic variations.

Main Results:

• Identification of a novel CT antigenic epitope encoded by MAGE-A6, containing a single nucleotide polymorphism (SNP).
• The identified SNP significantly enhanced the epitope's immunogenicity, triggering a strong immune response against tumor cells.
• Forward immunology successfully detected SNP-derived epitopes, unlike traditional reverse immunology approaches relying on reference sequences.

Conclusions:

• Forward immunology approaches, like cDNA expression cloning, are effective for discovering tumor antigens, including those with SNP-derived epitopes.
• SNP-dependent tumor antigens represent a promising avenue for developing targeted cancer immunotherapies.
• The study underscores the importance of considering genetic variations in antigen identification for effective cancer treatment strategies.